Clinical Development Stocks List
Symbol | Grade | Name | % Change | |
---|---|---|---|---|
AXSM | B | Axsome Therapeutics, Inc. | 0.50 | |
TGTX | B | TG Therapeutics, Inc. | 1.51 | |
GMED | A | Globus Medical, Inc. | -0.22 |
Related Industries: Biotechnology Diagnostics & Research Drug Manufacturers - Specialty & Generic Information Technology Services Medical Devices
Related Stock Lists:
Medicine
Organ Systems
Pain
Alzheimer's Disease
Antibody Drug Conjugate
Antidepressants
Back Pain
Biomaterial
Biopharmaceutical
Camidanlumab Tesirine
Cancer
Cd20
Central Nervous System Disorders
Chronic Condition
Chronic Pain
Deformity
Degenerative Disc Disease
Depression
Fusion Products
Healing
Symbol | Grade | Name | Weight | |
---|---|---|---|---|
HELX | D | Franklin Genomic Advancements ETF | 5.67 | |
BBP | C | BioShares Biotechnology Products Fund | 5.15 | |
SHLD | C | Global X Defense Tech ETF | 4.86 | |
HACK | B | ETFMG Prime Cyber Security ETF | 4.51 | |
SBIO | C | ALPS Medical Breakthroughs ETF | 4.37 |
Compare ETFs
- Clinical Development
Clinical development is the process of developing a new drug, medical device, or diagnostic test from the initial concept to the point of regulatory approval. It involves a series of steps, including preclinical research, clinical trials, regulatory review, and post-marketing surveillance. The goal of clinical development is to demonstrate the safety and efficacy of a product in order to obtain regulatory approval for marketing.
Recent Comments
- TraderMike on BOOT
- Dr_Duru on BOOT
- TraderMike on Stochastic Reached Oversold
- SuccessfulGrasshopper897 on Stochastic Reached Oversold
- Cos3 on Adding float as advanced filter criteria?
From the Blog
Featured Articles